Table 1.
Baseline Characteristics of Patients by Treatment Regimen
| Continuous | Cyclic | |||
|---|---|---|---|---|
| n | Mean(SD) | n | Mean(SD) | |
| Biometric | ||||
| Age (y) | 18 | 20.7 (3.9) | 17 | 21.1 (4.3) |
| Weight (kg) | 18 | 57.9 (6.8) | 17 | 55.9 (5.2) |
| BMI (kg/m2) | 18 | 20.7 (2.5) | 17 | 20.3 (1.8) |
| Systolic blood pressure (mm Hg) | 18 | 107.2 (6.7) | 17 | 101.8 (8.1) |
| Diastolic blood pressure (mm Hg) | 18 | 65.3 (6.1) | 17 | 60.6 (7.5) |
| Liver profile | ||||
| Bilirubin (umol/L) | 17 | 12.9 (3.8) | 15 | 14.0 (9.2) |
| Alkaline phosphates (J/L) | 16 | 57.4 (15.7) | 14 | 52.9 (21.7) |
| ALT (J/L) | 17 | 14.7 (4.7) | 15 | 13.4 (4.4) |
| Glucose (nmol/L) | 17 | 4.8 (0.4) | 15 | 5.2 (0.9) |
| Lipid profile | ||||
| Total Cholesterol (nmol/L) | 16 | 4.2 (1.1) | 15 | 4.1 (0.9) |
| LDL (nmol/L) | 16 | 2.5 (1.0) | 13 | 2.1 (0.9) |
| HDL (nmol/L) | 16 | 1.4 (0.3) | 13 | 1.7 (0.4) |
| Triglycerides (nmol/L) | 16 | 0.8 (0.2) | 15 | 0.8 (0.3) |
| Renal profile | ||||
| BUN (umol/L) | 13 | 246.2 (33.7) | 15 | 202.2 (77.5) |
| Creatinine (umol/L) | 17 | 81.7 (8.0) | 15 | 80.9 (9.9) |
| CBC | ||||
| White blood cell (x109/L) | 17 | 6.9 (2.2) | 15 | 6.4 (1.9) |
| Hemoglobin (g/L) | 18 | 134.1 (8.9) | 15 | 129.8 (9.8) |
| Hematocrit (L/L) | 18 | 0.4 (0.2) | 15 | 0.4 (0.0) |
| Platelet count (x109/L) | 18 | 262.3 (45.9) | 15 | 244.4 (41.0) |
| Ultrasound parameters | ||||
| Endometrial thickness (mm) | 16 | 7.2 (2.4) | 14 | 6.8 (3.1) |
| Total ovarian volume (cm3) | 16 | 11.1 (5.4) | 14 | 12.1 (7.0) |
SD, standard deviation; BMI, body mass index; ALT, alanine transminase; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BUN, blood urea nitrogen; CBC, complete blood count.